US Patent Issued to POXEL on June 3 for "Monohydrate potassium salt of a thienopyridone derivative and its preparation process" (French, Swiss, German Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,700, issued on June 3, was assigned to POXEL (Lyons, France).

"Monohydrate potassium salt of a thienopyridone derivative and its preparation process" was invented by Sebastien Bolze (Massieux, France), Marc Lanz (Reitnau, Switzerland), Deniz Arican (Lorrach, Germany), Anthony O'Sullivan (Basel, Switzerland), Sophie Hallakou-Bozec (Antony, France) and Laure Navarre (Lyons, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a process for preparing a monohydrate potassium salt of a 5 thienopyridone derivative. It also relates to a monohydrate potassium salt of a thienopyridone derivative and its use in medicine, in particular...